N°243 – Efficacy and tolerance of cannabidiol in the epilepsy treatment in patients with Rett syndrome: Experience in a single-center cohort

Béatrice Desnous(Inserm), Mathieu Milh(Inserm), Nathalie Villeneuve(Henri Gastaut Hospital), Géraldine Daquin(Hôpital de la Timone), Anne Lépine(Assistance Publique Hôpitaux de Marseille), Nathan J. Muller(Hôpital de la Timone), Thibault Beretti(Hôpital de la Timone)
Clinical Neurophysiology
May 16, 2023
10.1016/j.clinph.2023.03.233
Cited by 1

Related Papers

Mutations in GRIN2A and GRIN2B encoding regulatory subunits of NMDA receptors cause variable neurodevelopmental phenotypes
|Nature Genetics|2010|509
Diagnosis delay in West syndrome: misdiagnosis and consequences
|European Journal of Pediatrics|2012|88
Molecular and clinical descriptions of patients with <scp>GABA<sub>A</sub></scp> receptor gene variants (<i><scp>GABRA1</scp>, <scp>GABRB2</scp>, <scp>GABRB3</scp>, <scp>GABRG2</scp></i>): A cohort study, review of literature, and genotype–phenotype correlation
|Epilepsia|2022|80
Challenges and new perspectives of developmental cognitive EEG studies
|NeuroImage|2022|49
De novo mutations in CBL causing early-onset paediatric moyamoya angiopathy
|Journal of Medical Genetics|2017|41